Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 May;22(5):448-55.
doi: 10.1002/gps.1711.

A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI)

Steven Ferris  1 , Lon Schneider, Mildred Farmer, Gary Kay, Thomas Crook
Affiliations
Randomized Controlled Trial

A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI)

Steven Ferris et al. Int J Geriatr Psychiatry. 2007 May.

Abstract

Objectives: To determine the safety and efficacy of memantine in treating Age-Associated Memory Impairment (AAMI).

Methods: Sixty adults between 50-79 years of age meeting diagnostic requirements for AAMI were randomly assigned to either memantine (titrated to 20 mg) or a matched placebo and treated for 90 days. An extensive battery of computerized cognitive tests was administered at screening, baseline and, thereafter, at monthly intervals.

Results and conclusion: Study results suggest that the primary cognitive effects of memantine in this population are on attention and information processing speed, rather than on memory. There were no differences in adverse events between memantine and placebo.

PubMed Disclaimer

Publication types

MeSH terms

Substances